Vaccines, the most successful public health measure

Vaccines are one of the most cost-effective achievements in public health, significantly decreasing costs related to hospitalizations, treatments, disabilities, disease outbreaks, and productivity loss. They have helped to prevent more than 30 common infectious diseases[1] and save approximately 3 million lives a year globally [2].
MSD has played an important and defining role in the history of vaccines. We are proud of our rich biotechnical heritage that spans over a century, and of our proven track record in supplying well-tolerated and effective vaccines to millions of Europeans. Our best-in-class vaccines portfolio, which includes childhood, adolescent and adult products, has helped to prevent a number of diseases, including the prevention of now rare diseases, like measles and mumps, to diseases never thought preventable, like shingles and cervical cancer.

MSD continues its commitment to finding solutions to diseases that affect people of all ages everywhere in the world. MSD Vaccines is at the forefront of finding innovative solutions to help prevent infectious diseases globally.

Today, we are developing vaccines against new infections, improving existing vaccines and exploring ways of making our vaccines even more acceptable – for example, by maximizing the number of vaccines in a single injection.

Our ambition is to be the undisputed leader for vaccines, known for our innovation, expertise, ethics and dedication to protecting the lives of children and adults. Every child, woman and man deserves to be free from vaccine preventable diseases.

Our Products *

Vaccine Helps protect against
ROTATEQ® Rotavirus gastroenteritis
M-M-RVAXPRO® Measles, Mumps, Rubella
PROVARIVAX® Varicella (Chicken Pox)
GARDASIL® Human Papillomavirus diseases caused by 4 HPV Types
GARDASIL®Junior Human Papillomavirus diseases caused by 9 HPV Types
VAQTA®Junior Hepatitis A
VAQTA® Hepatitis A
HBVAXPRO®10 µg Hepatitis B
HBVAXPRO®40 µg Hepatitis B
PNEUMOVAX 23® Pneumococcal disease
ZOSTAVAX® Shingles

* Link to the SmPC of all the products above: website, accessed on January 24, 2017

[1] WHO, UNICEF, World Bank. State of the World’s Vaccines and Immunization, 3rd ed. Geneva, World Health Organization; 2009. last accessed November 2016

[2] World Health Organization. Immunization Coverage. April 2013; Fact Sheet 378. last accessed November 2016.

CORP-1207372-0000 Date of last revision 01/2017